809 related articles for article (PubMed ID: 27852284)
1. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
[TBL] [Abstract][Full Text] [Related]
2. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?
Guo R; Sun Y; Yu XL; Yin WJ; Li WF; Chen YY; Mao YP; Liu LZ; Li L; Lin AH; Ma J
Radiother Oncol; 2012 Sep; 104(3):294-9. PubMed ID: 22998947
[TBL] [Abstract][Full Text] [Related]
3. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
4. A Study of 358 Cases of Locally Advanced Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiation Therapy: Improving the Seventh Edition of the American Joint Committee on Cancer T-Staging System.
Zhou Q; He Y; Zhao Y; Wang Y; Kuang W; Shen L
Biomed Res Int; 2017; 2017():1419676. PubMed ID: 28265567
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Mao YP; Tang LL; Chen L; Sun Y; Qi ZY; Zhou GQ; Liu LZ; Li L; Lin AH; Ma J
Chin J Cancer; 2016 Dec; 35(1):103. PubMed ID: 28031050
[TBL] [Abstract][Full Text] [Related]
6. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Han L; Lin SJ; Pan JJ; Chen CB; Zhang Y; Zhang XC; Liao XY; Chen QS
Chin J Cancer; 2010 Feb; 29(2):145-50. PubMed ID: 20109341
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the distance between the primary tumor and brainstem in the patients with locally advanced nasopharyngeal carcinoma.
He Y; Wang Y; Shen L; Zhao Y; Cao P; Lei M; Chen D; Yang T; Shen L; Cao S
BMC Cancer; 2016 Feb; 16():114. PubMed ID: 26884234
[TBL] [Abstract][Full Text] [Related]
9. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X
Oncotarget; 2016 Dec; 7(52):86914-86925. PubMed ID: 27894100
[TBL] [Abstract][Full Text] [Related]
10. Prognostic efficacy of extensive invasion of primary tumor volume for T3-4 nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
Xue F; Ou D; Ou X; Zhou X; Hu C; He X
Oral Oncol; 2020 Jan; 100():104478. PubMed ID: 31759331
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Liang SB; Teng JJ; Hu XF; Yang XL; Luo M; Fang XN; Liu DS; Chen Y; Fu LW
BMC Cancer; 2017 Jul; 17(1):506. PubMed ID: 28754109
[TBL] [Abstract][Full Text] [Related]
13. Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patients.
Peng H; Chen L; Tang LL; Zhang Y; Li WF; Mao YP; Zhang F; Guo R; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
Oncotarget; 2016 Mar; 7(12):14963-72. PubMed ID: 26934649
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy.
Zhou GQ; Mao YP; Chen L; Li WF; Liu LZ; Sun Y; Chen Y; Tian L; Lin AH; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1090-7. PubMed ID: 21864993
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
16. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Wu Z; Su Y; Zeng RF; Gu MF; Huang SM
J Cancer Res Clin Oncol; 2014 Jan; 140(1):69-76. PubMed ID: 24173695
[TBL] [Abstract][Full Text] [Related]
19. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
